Lyell Wealth Management LP Has $333,000 Stake in Cigna Group $CI

Lyell Wealth Management LP decreased its stake in Cigna Group (NYSE:CIFree Report) by 9.7% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,006 shares of the health services provider’s stock after selling 108 shares during the period. Lyell Wealth Management LP’s holdings in Cigna Group were worth $333,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CI. Flaharty Asset Management LLC acquired a new position in Cigna Group in the first quarter valued at about $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group in the first quarter worth about $29,000. Activest Wealth Management increased its holdings in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC increased its holdings in shares of Cigna Group by 74.1% in the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after acquiring an additional 43 shares in the last quarter. Finally, Saudi Central Bank bought a new stake in shares of Cigna Group in the first quarter worth about $36,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Up 2.6%

NYSE:CI opened at $307.03 on Tuesday. Cigna Group has a twelve month low of $256.89 and a twelve month high of $350.00. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The business has a 50 day moving average price of $297.87 and a two-hundred day moving average price of $307.81. The company has a market cap of $81.96 billion, a P/E ratio of 16.76, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue was up 11.0% compared to the same quarter last year. During the same period last year, the company earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Insider Buying and Selling

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

CI has been the subject of several recent analyst reports. Cantor Fitzgerald restated an “overweight” rating and issued a $365.00 price target on shares of Cigna Group in a report on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on Cigna Group and gave the stock a “buy” rating in a report on Tuesday, August 5th. Barclays increased their price target on Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Finally, Guggenheim reaffirmed a “buy” rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average price target of $369.89.

Check Out Our Latest Analysis on Cigna Group

Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.